Skip to main content
YASHO INDUSTRIES LIMITED logo

YASHO INDUSTRIES LIMITED — Investor Relations & Filings

Ticker · YASHO ISIN · INE616Z01012 LEI · 335800JB9RDT2CJS4B70 BSE.NS Manufacturing
Open in API
Filings indexed 255 across all filing types
Latest filing 2025-11-06 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS YASHO

About YASHO INDUSTRIES LIMITED

https://www.yashoindustries.com/

Yasho Industries Limited specializes in the manufacturing and distribution of specialty chemicals, focusing on food antioxidants, aroma chemicals, rubber chemicals, lubricant additives, and specialty additives. The product range includes Butylated Hydroxy Anisole (BHA), Tert-Butyl Hydroquinone (TBHQ), and Ascorbyl Palmitate, which are utilized as preservatives in the food and beverage sectors. The company also produces a variety of rubber accelerators and antioxidants designed to enhance the durability and performance of rubber products. Additionally, its lubricant additives are engineered to improve the thermal and oxidative stability of industrial oils. Yasho Industries maintains a strong emphasis on research and development to support its diverse portfolio and meet global technical standards across multiple industrial applications.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Interim / Quarterly Report Classification · 90% confidence The document is a Board meeting outcome under SEBI Listing Regulations that includes the full unaudited standalone and consolidated financial results for the quarter and half‐year ended September 30, 2025, together with the auditor’s review report. It contains detailed financial statements (quarterly/interim financial data) rather than just key highlights or a summary link and is not merely an announcement of publication or a regulatory compliance letter. Therefore, it should be classified as an Interim/Quarterly Report (IR). H1 2026
2025-11-06 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 90% confidence The document is an announcement under SEBI Listing Regulations of the Board meeting outcome, including the full unaudited standalone and consolidated financial results for the quarter and half‐year ended September 30, 2025, together with the Limited Review Report by the statutory auditors. It is not merely a brief earnings release or a notice of publication but contains the substantive interim financial statements and auditor’s review, fitting the definition of an Interim / Quarterly Report. H1 2026
2025-11-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges (BSE and NSE) regarding the schedule of a conference call to discuss the company's Q2 and H1FY26 financial results. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The document does not contain any financial data or detailed analysis itself but announces the timing and participants of an upcoming conference call. This matches the definition of a Call Transcript (CT) document type, as it relates to a company conference call about financial results. However, since this is only an intimation of the schedule of the call and not the transcript or minutes of the call itself, it is not the transcript but an announcement of the call. Given the document length is short (2376 characters) and it is an announcement of the schedule, it fits best under Regulatory Filings (RNS) as a general regulatory announcement rather than the transcript or the earnings release itself. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2025-11-03 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-10-30 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges about a scheduled Board Meeting on November 6, 2025. It mentions the agenda to consider and approve unaudited financial results for the quarter and half year ended September 30, 2025, and a request for reclassification of promoter group shares. The document is short (2566 characters) and serves as an intimation or announcement of an upcoming board meeting and financial results approval, not the financial results report itself. It does not contain actual financial data or detailed analysis. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a regulatory announcement about a board meeting and financial results approval, not the report itself.
2025-10-30 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the inauguration of a new R&D Centre by Yasho Industries Limited. It is addressed to stock exchanges pursuant to SEBI regulations, indicating it is a regulatory disclosure. The content focuses on the event and company information, with no financial statements, management discussion, or detailed report data. The document length is about 5,230 characters, which is relatively short and typical for a press release. There is no indication that this is an annual or quarterly report, audit report, earnings release, or any other detailed financial or governance document. It is not a report publication announcement since it does not mention any report being attached or published. The document fits best under Regulatory Filings (RNS) as a general regulatory announcement and press release disclosure under SEBI regulations.
2025-10-29 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.